Literature DB >> 20371646

Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care.

Kylie Hill1, Roger S Goldstein, Gordon H Guyatt, Maria Blouin, Wan C Tan, Lori L Davis, Diane M Heels-Ansdell, Marko Erak, Pauline J Bragaglia, Itamar E Tamari, Richard Hodder, Matthew B Stanbrook.   

Abstract

BACKGROUND: People with known risk factors for chronic obstructive pulmonary disease (COPD) are important targets for screening and early intervention. We sought to measure the prevalence of COPD among such individuals visiting a primary care practitioner for any reason. We also evaluated the accuracy of prior diagnosis or nondiagnosis of COPD and identified associated clinical characteristics.
METHODS: We recruited patients from three primary care sites who were 40 years or older and had a smoking history of at least 20 pack-years. Participants were asked about respiratory symptoms and underwent postbronchodilator spirometry. COPD was defined as a ratio of forced expiratory volume in the first second of expiration to forced vital capacity (FEV(1)/FVC) of less than 0.7 and an FEV(1) of less than 80% predicted.
RESULTS: Of the 1459 patients who met the study criteria, 1003 (68.7%) completed spirometry testing. Of these, 208 were found to have COPD, for a prevalence of 20.7% (95% confidence interval 18.3%-23.4%). Of the 205 participants with COPD who completed the interview about respiratory symptoms before spirometry, only 67 (32.7%) were aware of their diagnosis before the study. Compared with patients in whom COPD had been correctly diagnosed before the study, those in whom COPD had been over-diagnosed or undiagnosed were similar in terms of age, sex, current smoking status and number of visits to a primary care practitioner because of a respiratory problem.
INTERPRETATION: Among adult patients visiting a primary care practitioner, as many as one in five with known risk factors met spirometric criteria for COPD. Underdiagnosis of COPD was frequent, which suggests a need for greater screening of at-risk individuals. Knowledge of the prevalence of COPD will help plan strategies for disease management.

Entities:  

Mesh:

Year:  2010        PMID: 20371646      PMCID: PMC2855915          DOI: 10.1503/cmaj.091784

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  32 in total

1.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

Authors:  D M Mannino; R C Gagnon; T L Petty; E Lydick
Journal:  Arch Intern Med       Date:  2000-06-12

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Effect of primary-care spirometry on the diagnosis and management of COPD.

Authors:  P P Walker; P Mitchell; F Diamantea; C J Warburton; L Davies
Journal:  Eur Respir J       Date:  2006-07-26       Impact factor: 16.671

4.  The natural history of chronic airflow obstruction.

Authors:  C Fletcher; R Peto
Journal:  Br Med J       Date:  1977-06-25

5.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

6.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

7.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

8.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

9.  Do GOLD stages of COPD severity really correspond to differences in health status?

Authors:  R Antonelli-Incalzi; C Imperiale; V Bellia; F Catalano; N Scichilone; R Pistelli; F Rengo
Journal:  Eur Respir J       Date:  2003-09       Impact factor: 16.671

10.  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Authors: 
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

View more
  91 in total

1.  A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.

Authors:  Francesca Polverino; Maria E Laucho-Contreras; Hans Petersen; Vanesa Bijol; Lynette M Sholl; Mary E Choi; Miguel Divo; Victor Pinto-Plata; Alfredo Chetta; Yohannes Tesfaigzi; Bartolomé R Celli; Caroline A Owen
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

Review 2.  Burden of chronic obstructive pulmonary disease: healthcare costs and beyond.

Authors:  Sara M May; James T C Li
Journal:  Allergy Asthma Proc       Date:  2015 Jan-Feb       Impact factor: 2.587

3.  Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.

Authors:  Truls S Ingebrigtsen; Jacob L Marott; Børge G Nordestgaard; Peter Lange; Jesper Hallas; Morten Dahl; Jørgen Vestbo
Journal:  J Gen Intern Med       Date:  2014-09-23       Impact factor: 5.128

4.  Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.

Authors:  Wouter van Dijk; Wan Tan; Pei Li; Best Guo; Summer Li; Andrea Benedetti; Jean Bourbeau
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

5.  Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario.

Authors:  Murray M Finkelstein; Kenneth R Chapman; R Andrew McIvor; Malcolm R Sears
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

6.  Identifying adults at risk of COPD who need confirmatory spirometry in primary care: Do symptom-based questions help?

Authors:  Kylie Hill; Richard Hodder; Maria Blouin; Diane Heels-Ansdell; Gordon Guyatt; Roger Goldstein
Journal:  Can Fam Physician       Date:  2011-02       Impact factor: 3.275

7.  Chronic obstructive pulmonary disease among lung cancer-free smokers: The importance of healthy controls.

Authors:  Michelle D Karpman; Ronald Eldridge; Jack L Follis; Carol J Etzel; Sanjay Shete; Randa A El-Zein
Journal:  Respir Investig       Date:  2017-12-06

Review 8.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

9.  Canadian practice assessment in chronic obstructive pulmonary disease: respiratory specialist physician perception versus patient reality.

Authors:  Paul Hernandez; Meyer S Balter; Jean Bourbeau; Charles K Chan; Darcy D Marciniuk; Shannon L Walker
Journal:  Can Respir J       Date:  2013 Mar-Apr       Impact factor: 2.409

Review 10.  Chronic obstructive pulmonary disease (COPD) evidentiary framework.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.